AlphaB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid beta-peptide and beta2-microglobulin.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMC 1316297)

Published in Biochem J on December 15, 2005

Authors

Bakthisaran Raman1, Tadato Ban, Miyo Sakai, Saloni Y Pasta, Tangirala Ramakrishna, Hironobu Naiki, Yuji Goto, Ch Mohan Rao

Author Affiliations

1: Centre for Cellular and Molecular Biology, Uppal Road, Hyderabad 500 007, India.

Articles citing this

Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc Natl Acad Sci U S A (2010) 3.50

The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β(1-40) peptide. Nat Struct Mol Biol (2011) 1.62

Chaperone networks: tipping the balance in protein folding diseases. Neurobiol Dis (2010) 1.42

Kinetics and thermodynamics of amyloid formation from direct measurements of fluctuations in fibril mass. Proc Natl Acad Sci U S A (2007) 1.29

Small heat shock proteins potentiate amyloid dissolution by protein disaggregases from yeast and humans. PLoS Biol (2012) 1.29

Novel roles for α-crystallins in retinal function and disease. Prog Retin Eye Res (2012) 1.17

Binding of the molecular chaperone αB-crystallin to Aβ amyloid fibrils inhibits fibril elongation. Biophys J (2011) 1.16

The interaction of alphaB-crystallin with mature alpha-synuclein amyloid fibrils inhibits their elongation. Biophys J (2010) 1.15

Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrils. Mol Biochem Parasitol (2009) 1.14

Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. Mol Cell Proteomics (2008) 1.14

The structured core domain of αB-crystallin can prevent amyloid fibrillation and associated toxicity. Proc Natl Acad Sci U S A (2014) 1.11

Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid. Proc Natl Acad Sci U S A (2007) 1.11

Small heat-shock proteins interact with a flanking domain to suppress polyglutamine aggregation. Proc Natl Acad Sci U S A (2010) 1.11

Receptor-associated protein interacts with amyloid-beta peptide and promotes its cellular uptake. J Biol Chem (2009) 1.00

Interactive sequences in the molecular chaperone, human alphaB crystallin modulate the fibrillation of amyloidogenic proteins. Int J Biochem Cell Biol (2007) 0.98

Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease. Curr Pharm Des (2008) 0.97

Site-directed mutations in the C-terminal extension of human alphaB-crystallin affect chaperone function and block amyloid fibril formation. PLoS One (2007) 0.95

Sequestration of toxic oligomers by HspB1 as a cytoprotective mechanism. Mol Cell Biol (2011) 0.94

Challenges associated with metal chelation therapy in Alzheimer's disease. J Alzheimers Dis (2009) 0.93

αB-Crystallin inhibits the cell toxicity associated with amyloid fibril formation by κ-casein and the amyloid-β peptide. Cell Stress Chaperones (2010) 0.92

The chaperone αB-crystallin uses different interfaces to capture an amorphous and an amyloid client. Nat Struct Mol Biol (2015) 0.92

The neuroendocrine protein 7B2 suppresses the aggregation of neurodegenerative disease-related proteins. J Biol Chem (2012) 0.91

AbetaPP-overexpression and proteasome inhibition increase alphaB-crystallin in cultured human muscle: relevance to inclusion-body myositis. Neuromuscul Disord (2006) 0.88

C-terminal interactions mediate the quaternary dynamics of αB-crystallin. Philos Trans R Soc Lond B Biol Sci (2013) 0.88

Mechanism of suppression of protein aggregation by α-crystallin. Int J Mol Sci (2009) 0.87

E. coli chaperones DnaK, Hsp33 and Spy inhibit bacterial functional amyloid assembly. Prion (2011) 0.87

Specific Chaperones and Regulatory Domains in Control of Amyloid Formation. J Biol Chem (2015) 0.86

Interaction between oligomers of stefin B and amyloid-beta in vitro and in cells. J Biol Chem (2009) 0.85

Behavioral defects in chaperone-deficient Alzheimer's disease model mice. PLoS One (2011) 0.84

Monitoring the interaction between β2-microglobulin and the molecular chaperone αB-crystallin by NMR and mass spectrometry: αB-crystallin dissociates β2-microglobulin oligomers. J Biol Chem (2013) 0.83

αB-crystallin (HspB5) in familial amyloidotic polyneuropathy. Int J Exp Pathol (2010) 0.81

Effect of αB-crystallin on protein aggregation in Drosophila. J Biomed Biotechnol (2012) 0.81

siRNA screen identifies QPCT as a druggable target for Huntington's disease. Nat Chem Biol (2015) 0.81

Small Heat-shock Proteins Prevent α-Synuclein Aggregation via Transient Interactions and Their Efficacy Is Affected by the Rate of Aggregation. J Biol Chem (2016) 0.79

Interaction of amyloid inhibitor proteins with amyloid beta peptides: insight from molecular dynamics simulations. PLoS One (2014) 0.77

Humoral response against small heat shock proteins in Parkinson's disease. PLoS One (2015) 0.76

Crystallins and neuroinflammation: The glial side of the story. Biochim Biophys Acta (2015) 0.76

Rescue of αB Crystallin (HSPB5) Mutants Associated Protein Aggregation by Co-Expression of HSPB5 Partners. PLoS One (2015) 0.76

Historical and Current Concepts of Fibrillogenesis and In vivo Amyloidogenesis: Implications of Amyloid Tissue Targeting. Front Mol Biosci (2016) 0.75

Chaperones as Suppressors of Protein Misfolded Oligomer Toxicity. Front Mol Neurosci (2017) 0.75

Functional Amyloid Protection in the Eye Lens: Retention of α-Crystallin Molecular Chaperone Activity after Modification into Amyloid Fibrils. Biomolecules (2017) 0.75

Articles cited by this

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science (2003) 18.18

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell (1993) 10.15

Alpha-crystallin can function as a molecular chaperone. Proc Natl Acad Sci U S A (1992) 8.10

Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science (1992) 5.22

A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet (1998) 4.75

Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem (1989) 4.43

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci U S A (1994) 4.33

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci (1999) 3.92

Alzheimer's disease: genotypes, phenotypes, and treatments. Science (1997) 3.72

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J Biol Chem (1996) 3.10

From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Q Rev Biophys (1998) 3.04

alpha B subunit of lens-specific protein alpha-crystallin is present in other ocular and non-ocular tissues. Biochem Biophys Res Commun (1989) 2.79

Genealogy of the alpha-crystallin--small heat-shock protein superfamily. Int J Biol Macromol (1998) 2.51

Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta. Proc Natl Acad Sci U S A (2003) 2.33

Structure and function of the small heat shock protein/alpha-crystallin family of molecular chaperones. Adv Protein Chem (2001) 2.21

Small heat-shock proteins and their potential role in human disease. Curr Opin Struct Biol (2000) 1.85

Direct observation of Abeta amyloid fibril growth and inhibition. J Mol Biol (2004) 1.82

Hypertonic stress induces alpha B-crystallin expression. Exp Eye Res (1992) 1.68

alpha B-crystallin is present in reactive glia in Creutzfeldt-Jakob disease. Acta Neuropathol (1992) 1.59

Conformational and functional differences between recombinant human lens alphaA- and alphaB-crystallin. J Biol Chem (1997) 1.52

Structural and functional consequences of the mutation of a conserved arginine residue in alphaA and alphaB crystallins. J Biol Chem (1999) 1.43

Expression of alpha B-crystallin in Alzheimer's disease. Acta Neuropathol (1994) 1.38

Critical balance of electrostatic and hydrophobic interactions is required for beta 2-microglobulin amyloid fibril growth and stability. Biochemistry (2005) 1.34

Chaperone-like activity and quaternary structure of alpha-crystallin. J Biol Chem (1994) 1.34

Expression of the alpha-crystallin/small heat-shock protein/molecular chaperone genes in the lens and other tissues. Adv Enzymol Relat Areas Mol Biol (1994) 1.32

Amyloid fibril formation in the context of full-length protein: effects of proline mutations on the amyloid fibril formation of beta2-microglobulin. J Biol Chem (2003) 1.31

Differential temperature-dependent chaperone-like activity of alphaA- and alphaB-crystallin homoaggregates. J Biol Chem (1999) 1.20

The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity. Biochem Biophys Res Commun (1999) 1.19

The molecular chaperone, alpha-crystallin, inhibits amyloid formation by apolipoprotein C-II. J Biol Chem (2001) 1.17

A dynamic quaternary structure of bovine alpha-crystallin as indicated from intermolecular exchange of subunits. Biochemistry (1990) 1.13

Alpha B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease. J Neurol Sci (1993) 1.12

Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med (1986) 1.10

Functional elements in molecular chaperone alpha-crystallin: identification of binding sites in alpha B-crystallin. Biochem Biophys Res Commun (1997) 1.09

Role of the conserved SRLFDQFFG region of alpha-crystallin, a small heat shock protein. Effect on oligomeric size, subunit exchange, and chaperone-like activity. J Biol Chem (2003) 1.08

Small heat shock proteins inhibit in vitro A beta(1-42) amyloidogenesis. FEBS Lett (1997) 1.07

Interaction of human recombinant alphaA- and alphaB-crystallins with early and late unfolding intermediates of citrate synthase on its thermal denaturation. FEBS Lett (2001) 1.01

Domain swapping in human alpha A and alpha B crystallins affects oligomerization and enhances chaperone-like activity. J Biol Chem (2000) 0.96

Effect of the chaperone-like alpha-crystallin on the refolding of lysozyme and ribonuclease A. FEBS Lett (1997) 0.94

Interaction between beta-amyloid and lens alphaB-crystallin. FEBS Lett (2000) 0.94

Role of the C-terminal extensions of alpha-crystallins. Swapping the C-terminal extension of alpha-crystallin to alphaB-crystallin results in enhanced chaperone activity. J Biol Chem (2002) 0.94

The chaperone-like alpha-crystallin forms a complex only with the aggregation-prone molten globule state of alpha-lactalbumin. Biochem Biophys Res Commun (1998) 0.92

Unfolding and refolding of a quinone oxidoreductase: alpha-crystallin, a molecular chaperone, assists its reactivation. Biochem J (2001) 0.89

Specific dissociation of alpha B subunits from alpha-crystallin. Biochim Biophys Acta (1988) 0.87

The selective inhibition of serpin aggregation by the molecular chaperone, alpha-crystallin, indicates a nucleation-dependent specificity. J Biol Chem (2003) 0.85

Apolipoprotein E inhibits the depolymerization of beta 2-microglobulin-related amyloid fibrils at a neutral pH. Biochemistry (2001) 0.84

Amidation of beta-amyloid peptide strongly reduced the amyloidogenic activity without alteration of the neurotoxicity. J Neurochem (1997) 0.80

Dialysis-related amyloidosis. Nephrol Dial Transplant (1998) 0.79

Articles by these authors

Imprinting along the Kcnq1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes. Nat Genet (2004) 3.33

Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. Nat Struct Biol (2002) 2.99

The organization of histone H3 modifications as revealed by a panel of specific monoclonal antibodies. Cell Struct Funct (2008) 2.75

Allele-specific histone lysine methylation marks regulatory regions at imprinted mouse genes. EMBO J (2002) 2.40

A toxic monomeric conformer of the polyglutamine protein. Nat Struct Mol Biol (2007) 2.33

Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res (2004) 2.23

Site-specific analysis of histone methylation and acetylation. Methods Mol Biol (2004) 1.97

Direct observation of Abeta amyloid fibril growth and inhibition. J Mol Biol (2004) 1.82

Protein folding by the effects of macromolecular crowding. Protein Sci (2004) 1.71

3D structure of amyloid protofilaments of beta2-microglobulin fragment probed by solid-state NMR. Proc Natl Acad Sci U S A (2006) 1.70

Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J Neurochem (2003) 1.64

One Argonaute family member, Eif2c2 (Ago2), is essential for development and appears not to be involved in DNA methylation. Genomics (2007) 1.56

Direct observation of amyloid fibril growth monitored by thioflavin T fluorescence. J Biol Chem (2003) 1.52

A seed for Alzheimer amyloid in the brain. J Neurosci (2004) 1.45

Low concentrations of sodium dodecyl sulfate induce the extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH. Biochemistry (2004) 1.39

Core and heterogeneity of beta2-microglobulin amyloid fibrils as revealed by H/D exchange. J Mol Biol (2004) 1.35

Critical balance of electrostatic and hydrophobic interactions is required for beta 2-microglobulin amyloid fibril growth and stability. Biochemistry (2005) 1.34

Amyloid fibril formation in the context of full-length protein: effects of proline mutations on the amyloid fibril formation of beta2-microglobulin. J Biol Chem (2003) 1.31

Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH. J Am Soc Nephrol (2004) 1.29

Ultrasonication-induced amyloid fibril formation of beta2-microglobulin. J Biol Chem (2005) 1.27

Investigation of a peptide responsible for amyloid fibril formation of beta 2-microglobulin by achromobacter protease I. J Biol Chem (2001) 1.27

Nuclear magnetic resonance characterization of the refolding intermediate of beta2-microglobulin trapped by non-native prolyl peptide bond. J Mol Biol (2005) 1.25

Branching in amyloid fibril growth. Biophys J (2009) 1.21

Distinguishing crystal-like amyloid fibrils and glass-like amorphous aggregates from their kinetics of formation. Proc Natl Acad Sci U S A (2012) 1.19

The IXI/V motif in the C-terminal extension of alpha-crystallins: alternative interactions and oligomeric assemblies. Mol Vis (2004) 1.16

Seeding-dependent propagation and maturation of amyloid fibril conformation. J Mol Biol (2005) 1.15

RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy. Dermatol Res Pract (2011) 1.15

Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid. Proc Natl Acad Sci U S A (2007) 1.11

Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro. Biochim Biophys Acta (2004) 1.10

Association of alphaB-crystallin, a small heat shock protein, with actin: role in modulating actin filament dynamics in vivo. J Mol Biol (2006) 1.10

Glycosaminoglycan and proteoglycan inhibit the depolymerization of beta2-microglobulin amyloid fibrils in vitro. Kidney Int (2003) 1.09

Mammalian Hsp22 is a heat-inducible small heat-shock protein with chaperone-like activity. Biochem J (2004) 1.09

Principal component analysis of the pH-dependent conformational transitions of bovine beta-lactoglobulin monitored by heteronuclear NMR. Proc Natl Acad Sci U S A (2007) 1.09

Fibrillogenic and non-fibrillogenic ensembles of SDS-bound human alpha-synuclein. J Mol Biol (2006) 1.09

Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease. J Neurochem (2002) 1.09

Structural defects and the diagnosis of amyloidogenic propensity. Proc Natl Acad Sci U S A (2003) 1.08

Role of the conserved SRLFDQFFG region of alpha-crystallin, a small heat shock protein. Effect on oligomeric size, subunit exchange, and chaperone-like activity. J Biol Chem (2003) 1.08

Kinetic modeling and determination of reaction constants of Alzheimer's beta-amyloid fibril extension and dissociation using surface plasmon resonance. Biochemistry (2002) 1.08

Development of a technique for the investigation of folding dynamics of single proteins for extended time periods. Proc Natl Acad Sci U S A (2007) 1.07

A comprehensive model for packing and hydration for amyloid fibrils of beta2-microglobulin. J Biol Chem (2008) 1.07

Mechanism by which the amyloid-like fibrils of a beta 2-microglobulin fragment are induced by fluorine-substituted alcohols. J Mol Biol (2006) 1.06

Ultrasonication-dependent production and breakdown lead to minimum-sized amyloid fibrils. Proc Natl Acad Sci U S A (2009) 1.06

Dissolution of beta2-microglobulin amyloid fibrils by dimethylsulfoxide. J Biochem (2003) 1.06

Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. Neuropharmacology (2005) 1.05

Revisiting the mechanism of the autoactivation of the complement protease C1r in the C1 complex: structure of the active catalytic region of C1r. Mol Immunol (2007) 1.05

Increase in the conformational flexibility of beta 2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis. Protein Sci (2004) 1.04

Structure, folding dynamics, and amyloidogenesis of D76N β2-microglobulin: roles of shear flow, hydrophobic surfaces, and α-crystallin. J Biol Chem (2013) 1.04

The role of disulfide bond in the amyloidogenic state of beta(2)-microglobulin studied by heteronuclear NMR. Protein Sci (2002) 1.04

Real-time and single fibril observation of the formation of amyloid beta spherulitic structures. J Biol Chem (2006) 1.03

Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils. FEBS Lett (2004) 1.03

Visualization and classification of amyloid beta supramolecular assemblies. Biochemistry (2007) 1.02

Molecular Network Associated with MITF in Skin Melanoma Development and Progression. J Skin Cancer (2011) 1.01

Direct measurement of the thermodynamic parameters of amyloid formation by isothermal titration calorimetry. J Biol Chem (2004) 1.01

Effect of phosphorylation on alpha B-crystallin: differences in stability, subunit exchange and chaperone activity of homo and mixed oligomers of alpha B-crystallin and its phosphorylation-mimicking mutant. J Mol Biol (2007) 1.01

Hsp90 inhibitors, GA and 17AAG, lead to ER stress-induced apoptosis in rat histiocytoma. Biochem Pharmacol (2009) 1.00

HSP90 modulates actin dynamics: inhibition of HSP90 leads to decreased cell motility and impairs invasion. Biochim Biophys Acta (2010) 1.00

The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbeta. Curr Pharm Des (2006) 0.99

Seeding-dependent maturation of beta2-microglobulin amyloid fibrils at neutral pH. J Biol Chem (2005) 0.98

Amyloid nucleation triggered by agitation of beta2-microglobulin under acidic and neutral pH conditions. Biochemistry (2008) 0.98

Transmission of amyloidosis in offspring of mice with AApoAII amyloidosis. Am J Pathol (2006) 0.98

Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrils. Am J Pathol (2007) 0.98

Protein folding: could hydrophobic collapse be coupled with hydrogen-bond formation? FEBS Lett (2003) 0.98